Latest Breaking News On - National pharmaceutical regulatory division - Page 7 : comparemela.com
As Covid vaccinations gather pace, Khairy admits still a ways to go in bid to immunise 80pc of Malaysians | Malaysia
malaymail.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from malaymail.com Daily Mail and Mail on Sunday newspapers.
Our vaccination rate accelerated in line with Covid-19 situation
harakahdaily.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from harakahdaily.net Daily Mail and Mail on Sunday newspapers.
Vaccination accelerated in line with current Covid-19 situation: Khairy | Daily Express Online
dailyexpress.com.my - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailyexpress.com.my Daily Mail and Mail on Sunday newspapers.
The Health Ministry said the Drug Control Authority (DCA) made the decision at a meeting yesterday.
“This conditional registration approval requires information on the quality, safety and effectiveness of the vaccine product to be monitored and evaluated based on the latest data from time to time.
“It is to ensure that the benefits outweigh the risks for the vaccines,” it said in a statement.
The ministry said it strove to combat the pandemic by ensuring an adequate supply of vaccines that had been evaluated for quality, safety and effectiveness by the National Pharmaceutical Regulatory Division and approved by the DCA.
PETALING JAYA: The Sinopharm and Johnson & Johnson Covid-19 vaccines have been granted conditional approval for use in the country’s National Covid-19 Immunisation Programme, says the Health Ministry.
In a statement, the ministry said the Drug Control Authority (DCA) made the decision at a meeting on Friday (July 16).
“This conditional registration approval requires information on the quality, safety and effectiveness of the vaccine product to be monitored and evaluated based on the latest data from time to time.
“It is to ensure that the benefit over risk for the vaccines remain positive,” it said.
The ministry said it strives to combat the pandemic by ensuring adequate supply of vaccines that have been evaluated for quality, safety and effectiveness by the National Pharmaceutical Regulatory Division and approved by the DCA.